Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide

BACKGROUND: Chemoresistance of glioblastoma multiforme (GBM) has been attributed to the presence within the tumor of cancer stem cells (GSCs). The standard therapy for GBM consists of surgery followed by radiotherapy and the chemotherapeutic agent temozolomide (TMZ). However, TMZ efficacy is limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Tentori, Lucio, Ricci-Vitiani, Lucia, Muzi, Alessia, Ciccarone, Fabio, Pelacchi, Federica, Calabrese, Roberta, Runci, Daniele, Pallini, Roberto, Caiafa, Paola, Graziani, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975727/
https://www.ncbi.nlm.nih.gov/pubmed/24593254
http://dx.doi.org/10.1186/1471-2407-14-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975727/
https://www.ncbi.nlm.nih.gov/pubmed/24593254
http://dx.doi.org/10.1186/1471-2407-14-151

Ejemplares similares